about
Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer.Evaluation of prediction models for the staging of prostate cancer.The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.Novel predictive tools for Irish radical prostatectomy pathological outcomes: development and validation.High dose statin prophylaxis in cardiopulmonary bypass related surgery: clinical utility.Patented prostate cancer biomarkers.Interleukin-1beta mediates LPS-induced inhibition of apoptosis in retinoic acid-differentiated HL-60 cells.Commercialized biomarkers: new horizons in prostate cancer diagnostics.Physical activity and its mechanistic effects on prostate cancer.Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.Relationship between serum response factor and androgen receptor in prostate cancer.Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.A gender comparison of postobstructive injury in the rat kidney.The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases.Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo.Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.Prostate cancer risk assessment tools in an unscreened population.Improving multivariable prostate cancer risk assessment using the Prostate Health Index.Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral population.The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.Neonatal brain injury and systemic inflammation: modulation by activated protein C ex vivo.Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts.MARCKS promotes invasion and is associated with biochemical recurrence in prostate cancer.Pre-operative determination of an individual's neutrophil response: a potential predictor of early cardiac transplant cellular rejection.Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.Ensemble based system for whole-slide prostate cancer probability mapping using color texture features.Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.Maternal and neonatal lipopolysaccharide and Fas responses are altered by antenatal risk factors for sepsis.The single insult of hypoxic preconditioning induces an antiapoptotic response in human proximal tubular cells, in vitro, across cold storage.Persistent systemic monocyte and neutrophil activation in neonatal encephalopathy.Persistent systemic monocyte and neutrophil activation in neonatal encephalopathy.Advances in Precision Medicine: Tailoring Individualized Therapies.Serial cytokine alterations and abnormal neuroimaging in newborn infants with encephalopathy.Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.Predicting outcome: role of gene signatures.Role of serum response factor expression in prostate cancer biochemical recurrence.Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research.
P50
Q33774464-11C17693-933A-4324-872C-1E53A0630827Q35044520-8022FE1D-A778-49B6-9B6C-59FB14B5EB0DQ36294460-B62F96DF-C703-49F9-A09F-29FD7DE92F0EQ37550110-584686A5-43F6-414B-A67A-1159020FCFB3Q37731694-88C12D71-9B34-4249-A305-1E1FDF4517FFQ38023110-9359F983-6FA0-46A7-8F82-9C7000969031Q38293336-7BFB3922-2B14-4650-A79B-64F7D7D0F39FQ38364797-C2BD59CB-7FAC-4DAB-B26F-45C0F41C8EE7Q38387928-8686AAB1-63F2-4E75-AD5F-A2A8515169F6Q38837742-E65D96A8-F44D-4C8A-A870-AE9FEFBC7C26Q38845729-22B3A934-4312-456F-AFB9-797F0DD8912CQ38871314-575BD29F-683A-4600-9188-BFAC756EB93AQ39283346-FE2C6C79-2D5E-4C0A-AE71-B3BB2FEF2990Q39312424-1B493D8C-A2BB-4EE1-AACC-B833EE09C616Q39623350-3DD8E475-44A6-4117-BEAA-72A27B18AAC3Q39674709-B06D4AB5-A6C4-4B80-A918-D1ABDC11F9FAQ39866694-FA0E7690-9367-4EFF-93BA-4873256330EFQ39949352-04795A42-12CE-4C9F-B00A-780E18AE81A4Q40212530-C3D5B3D1-6CEA-4926-BAEA-8A536D037E86Q40270088-7858FEA6-561D-471A-A314-3609C7D5C4FCQ41114614-BDE2F504-05BC-4E36-BC40-E4FF2787407CQ41127809-1ED2382D-019A-47B9-B316-FB753B6DEBB1Q41746195-28C03A13-A3AF-4481-B6FB-96DBDEBA764EQ42317551-F9BEE431-940F-42F9-BD8E-3F3CED0D6A99Q42474356-69BDFBBE-E8B1-4482-B75C-916EE889ACBBQ42700841-E2AED8C1-C70F-412F-8337-A67B891D7E61Q43270900-52CAA102-87A3-4E3F-8AE8-EEE2AEBDD2F5Q43547830-3750D0A0-8E63-42BE-BAEC-4A03332ECDBAQ43585261-5657DA60-27FF-459D-9D73-8CE0DA75B2A7Q46055526-38B013F8-2E22-4BB0-9C4C-0021204B06EAQ46337730-F7C9A6B5-6B06-48C2-8ADF-F767E75EA2B3Q46377730-2D664940-9836-46D8-997F-3E75A321B094Q46770661-408071D2-9F15-4150-B14B-3BF1296D7564Q46776949-0FAC3A41-B186-4782-B47E-EAF5EC43DFE5Q47160721-56D97257-CAEA-4230-A444-18BA1ABDFC75Q47583876-B6113A9C-AC93-44A2-B79E-4D85AFFA9BE6Q47758797-CEEE5B79-8B8B-4CA7-AAEE-C8CF16200787Q48092525-A59F6EBE-96E2-44CD-A711-E13E75C572D2Q52613870-14DB7304-6F92-4D77-B698-F2C00EAE392DQ53066145-A7D13151-946A-45EF-88ED-253FC51C7F04
P50
description
researcher ORCID ID = 0000-0001-8831-3244
@en
wetenschapper
@nl
name
Ronald William Watson
@ast
Ronald William Watson
@en
Ronald William Watson
@es
Ronald William Watson
@nl
type
label
Ronald William Watson
@ast
Ronald William Watson
@en
Ronald William Watson
@es
Ronald William Watson
@nl
prefLabel
Ronald William Watson
@ast
Ronald William Watson
@en
Ronald William Watson
@es
Ronald William Watson
@nl
P108
P31
P496
0000-0001-8831-3244